STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Larimar Therapeutics, Inc.

Filed

September 19, 2022

Period of Report

September 16, 2022

Accession Number

0001062993-22-019646